Yet another new test will soon be available that claims to be able to differentiate with relative accuracy between clinically significant and clinically insignificant types of prostate cancer (again based on actual prostate cancer tissue from a biopsy sample or a surgical specimen). … READ MORE …
Filed under: Diagnosis, Risk | Tagged: Diagnosis, prognosis, ProMark, risk | 2 Comments »